Global Home Infusion Therapy Market Anticipated to Reach $38.7 Billion by 2026

    NEXT STORY
    Change in Orion Corporation’s holding of treasury shares
    PREV STORY
    The World Market of Blood Preparation (2019-2026): Direct Factor Xa Inhibitors is the Most Lucrative Segment
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Horizon Pharma plc Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

    DUBLIN, Ireland, Sept. 13, 2017 (GLOBE NEWSWIRE) -- Horizon Pharma plc (NASDAQ:HZNP), a biopharmaceutical ...

    author_avatar
    NASDAQ Market News

    Spring Bank Pharmaceuticals and F-star Therapeutics Agree to Combine to Pursue Mission of Creating Next Generation Immunotherapies

    author_avatar
    NASDAQ Market News

    Dynavax Technologies Corporation Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)

    BERKELEY, Calif., Feb. 02, 2018 (GLOBE NEWSWIRE) -- Dynavax Technologies Corporation (NASDAQ:DVAX) today announced ...

    author_avatar
    NASDAQ Market News